12
TITLE: Adenosine receptors in neurodegenerative diseases
AUTHORS: Blum, D; Lopes, LV;
PUBLISHED: 2017, SOURCE: Adenosine Receptors in Neurodegenerative Diseases
INDEXED IN: Scopus
13
TITLE: A(2A) adenosine receptor deletion is protective in a mouse model of Tauopathy
AUTHORS: Laurent, C; Burnouf, S; Ferry, B; Batalha, VL; Coelho, JE; Baqi, Y; Malik, E; Mariciniak, E; Parrot, S; Van der Jeugd, A; Faivre, E; Flaten, V; Ledent, C; D'Hooge, R; Sergeant, N; Hamdane, M; Humez, S; Mueller, CE; Lopes, LV; Buee, L; Blum, D; ...More
PUBLISHED: 2016, SOURCE: MOLECULAR PSYCHIATRY, VOLUME: 21, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
14
TITLE: The caffeine-binding adenosine A(2A) receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function  Full Text
AUTHORS: Vania L Batalha; Diana G Ferreira; Joana E Coelho; Jorge S Valadas; Rui Gomes; Mariana Temido Ferreira; Tatiana Shmidt; Younis Baqi; Luc Buee; Christa E Mueller; Malika Hamdane; Tiago F Outeiro; Michael Bader; Sebastiaan H Meijsing; Ghazaleh Sadri Vakili; David Blum; Luisa V Lopes;
PUBLISHED: 2016, SOURCE: SCIENTIFIC REPORTS, VOLUME: 6
INDEXED IN: Scopus WOS CrossRef
15
TITLE: Mortality in Phase III Studies of Adjunctive and Monotherapy Eslicarbazepine Acetate (ESL) in Patients with Partial-Onset Seizures (POS)
AUTHORS: Eugen Trinka; Andrew Cole; Eva Andermann; Helena Gama; Francisco Rocha; David Bium; Todd Grinnell; Hailong L Cheng; Philippe Ryvlin;
PUBLISHED: 2016, SOURCE: 68th Annual Meeting of the American-Academy-of-Neurology (AAN) in NEUROLOGY, VOLUME: 86
INDEXED IN: WOS
16
TITLE: Eslicarbazepine Acetate Associated with Reduced Seizure Severity in Addition to Reduced Seizure Frequency
AUTHORS: Joyce Cramer; Fulton Velez; Kathryn Anastassopoulos; Christopher C Bond; Xuezhe Z Wang; David Blum; Joana Moreira; Francisco Rocha;
PUBLISHED: 2016, SOURCE: 68th Annual Meeting of the American-Academy-of-Neurology (AAN) in NEUROLOGY, VOLUME: 86
INDEXED IN: WOS
17
TITLE: Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial  Full Text
AUTHORS: Michael R Sperling; Bassel Abou Khalil; Jay Harvey; Joanne B Rogin; Arnaud Biraben; Carlo A Galimberti; Pedro A Kowacs; Seung Bong Hong; Hailong Cheng; David Blum; Teresa Nunes; Patricio Soares da Silva;
PUBLISHED: 2015, SOURCE: EPILEPSIA, VOLUME: 56, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef
18
TITLE: Mutant huntingtin alters Tau phosphorylation and subcellular distribution
AUTHORS: David Blum; Federico Herrera; Laetitia Francelle; Tiago Mendes; Marie Basquin; Helene Obriot; Dominique Demeyer; Nicolas Sergeant; Ellen Gerhardt; Emmanuel Brouillet; Luc Buee; Tiago F Outeiro;
PUBLISHED: 2015, SOURCE: HUMAN MOLECULAR GENETICS, VOLUME: 24, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
19
TITLE: Severity and burden of partial-onset seizures in a phase III trial of eslicarbazepine acetate  Full Text
AUTHORS: Joyce A Cramer; Fulton F Velez; Kathryn P Anastassopoulos; Christopher C Bond; Frank G Gilliam; Philippe Ryvlin; Luigi M Specchio; Xuezhe Z Wang; David Blum; Joana Moreira; Francisco Rocha;
PUBLISHED: 2015, SOURCE: EPILEPSY & BEHAVIOR, VOLUME: 53
INDEXED IN: Scopus WOS CrossRef
20
TITLE: Design and synthesis of fused tetrahydroisoquinoline-iminoimidazolines  Full Text
AUTHORS: Valeria Moas Heloire; Nicolas Renault; Vania Batalha; Angela R Rincon Arias; Mathieu Marchivie; Said Yous; Noemie Deguine; Luc Buee; Philippe Chavatte; David Blum; Luisa Lopes; Patricia Melnyk; Laurence Agouridas;
PUBLISHED: 2015, SOURCE: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, VOLUME: 106
INDEXED IN: WOS
Page 2 of 3. Total results: 21.